Urgent

Neonatal abstinence syndrome — severe/pharmacological escalation

Morphine titration, adjuncts · Paediatric
Physician-written · Verified by three sets of doctors · Reviewed November 2026

Bedside summary

When non-pharmacological care fails to control neonatal abstinence (persistently high withdrawal scores, poor feeding, weight loss, seizures or severe GI/autonomic signs), pharmacological treatment is escalated. For opioid withdrawal, oral morphine is first-line and titrated to symptom control, with adjunctive agents added for refractory cases.

Red flags

  • Seizures or severe autonomic instability
  • Severe feeding intolerance with dehydration/weight loss
  • Scores remaining high despite escalating first-line therapy
  • Apnoea or excessive sedation from treatment
  • Features suggesting sepsis/metabolic cause rather than withdrawal

Assessment

Differential diagnosis

  • Opioid neonatal abstinence (commonest driver of escalation)
  • Polydrug/benzodiazepine withdrawal
  • Sepsis/meningitis (mimics withdrawal)
  • Hypoglycaemia, hypocalcaemia or hypomagnesaemia
  • Hyperthyroidism
  • Hypoxic-ischaemic or structural CNS pathology with irritability

Investigations

  • Serial standardised withdrawal scoring (e.g. modified Finnegan or ESC function-based assessment)
  • Maternal/neonatal drug history and toxicology where consented/indicated
  • Glucose, calcium, magnesium and electrolytes (exclude metabolic mimics)
  • Septic screen if atypical features or seizures
  • Weight and feeding/output monitoring
  • Review of all maternal medications (including prescribed opioids, SSRIs)

Management

  • Maximise non-pharmacological measures first: low-stimulation environment, swaddling, responsive feeding, maternal rooming-in and skin-to-skin
  • Use a validated, consistent scoring tool and clear treatment thresholds to decide on escalation
  • Exclude and correct metabolic causes and sepsis before attributing all signs to withdrawal
  • Start oral morphine for significant opioid withdrawal and titrate the dose upward to control scores
  • Increase the morphine dose stepwise according to scoring until symptoms are controlled
  • Add a second agent (e.g. clonidine or phenobarbital) for withdrawal refractory to escalating morphine or for polydrug exposure
  • Treat seizures promptly and reassess the diagnosis if they occur
  • Once stable for a defined period, wean the opioid gradually (e.g. 10% reductions) guided by scores
  • Support breastfeeding where not contraindicated and involve safeguarding/social care as appropriate
  • Plan a safe discharge with community follow-up and parental education once off/weaning treatment

Drugs & doses

Morphine sulfate oral solution 40 microgram/kg/dose (0.04 mg/kg) every 3-4 h, titrated up by scores (some protocols to ~0.1-0.2 mg/kg/dose)
Clonidine 0.5-1 microgram/kg/dose PO every 3-6 h as an adjunct for refractory withdrawal
Phenobarbital loading 10-20 mg/kg then maintenance ~5 mg/kg/day (adjunct, esp. non-opioid/polydrug)
Wean the primary agent gradually (e.g. ~10% every 24-48 h) once scores controlled

Disposition

Manage on the neonatal/transitional care unit with rooming-in; wean pharmacotherapy by scoring. Multidisciplinary discharge planning with community, safeguarding and follow-up support.

Complications & pitfalls

  • Dehydration and failure to thrive
  • Seizures
  • Over-sedation/respiratory depression from pharmacotherapy
  • Prolonged hospital stay and impaired bonding
  • Safeguarding concerns and disrupted care at home

Exam pearls

  • Optimise non-pharmacological care first — it reduces the need for and dose of medication
  • Match the drug to the exposure: opioids for opioid withdrawal, adjuncts for refractory/polydrug cases
  • Function-based assessment (feeding, sleeping, consoling) is increasingly favoured over symptom counting to guide treatment
  • Wean slowly and by score, not by a fixed calendar, to avoid rebound

Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.